| ESTRO ACROP consensus guideline on CT-and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer C Salembier, G Villeirs, B De Bari, P Hoskin, BR Pieters, M Van Vulpen, ... Radiotherapy and Oncology 127 (1), 49-61, 2018 | 70 | 2018 |
| Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review F Alongi, B De Bari, F Campostrini, S Arcangeli, DV Matei, E Lopci, ... Critical reviews in oncology/hematology 88 (3), 550-563, 2013 | 61 | 2013 |
| EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU … JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... European urology 77 (2), 223-250, 2020 | 46 | 2020 |
| Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy J Castelli, B De Bari, A Depeursinge, A Simon, A Devillers, GR Jimenez, ... Critical reviews in oncology/hematology 108, 40-51, 2016 | 43 | 2016 |
| Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database S Salas, N Resseguier, JY Blay, A Le Cesne, A Italiano, C Chevreau, ... Annals of oncology 28 (8), 1779-1787, 2017 | 42 | 2017 |
| Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies M Balducci, A Fiorentino, P De Bonis, S Chiesa, S Manfrida, ... Medical Oncology 29 (5), 3478-3483, 2012 | 42 | 2012 |
| Adaptive radiotherapy for head and neck cancer J Castelli, A Simon, C Lafond, N Perichon, B Rigaud, E Chajon, B De Bari, ... Acta Oncologica 57 (10), 1284-1292, 2018 | 40* | 2018 |
| Spinal metastases: Is stereotactic body radiation therapy supported by evidences? B De Bari, F Alongi, G Mortellaro, R Mazzola, L Schiappacasse, ... Critical reviews in oncology/hematology 98, 147-158, 2016 | 40 | 2016 |
| Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms M Balducci, S Chiesa, S Manfrida, E Rossi, T Za, V Frascino, B De Bari, ... Strahlentherapie und Onkologie 187 (2), 114-119, 2011 | 38 | 2011 |
| Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist J Cacicedo, A Navarro, O Del Hoyo, A Gomez-Iturriaga, F Alongi, ... The British journal of radiology 89 (1067), 20160217, 2016 | 36 | 2016 |
| Increased expression of cyclin E is associated with an increased resistance to doxorubicin in rat fibroblasts A Sgambato, A Camerini, G Pani, R Cangiano, B Faraglia, G Bianchino, ... British journal of cancer 88 (12), 1956-1962, 2003 | 36 | 2003 |
| The “BUONGIORNO” project: burnout syndrome among young Italian radiation oncologists P Ciammella, B De Bari, A Fiorentino, P Franco, S Cavuto, F Alongi, L Livi, ... Cancer investigation 31 (8), 522-528, 2013 | 34 | 2013 |
| Extreme hypofractionation for early prostate cancer: biology meets technology B De Bari, S Arcangeli, D Ciardo, R Mazzola, F Alongi, EG Russi, ... Cancer treatment reviews 50, 48-60, 2016 | 33 | 2016 |
| Four years with FALCON–an ESTRO educational project: achievements and perspectives JG Eriksen, C Salembier, S Rivera, B De Bari, D Berger, G Mantello, ... Radiotherapy and Oncology 112 (1), 145-149, 2014 | 33 | 2014 |
| Salvage therapy of small volume prostate cancer nodal failures: a review of the literature B De Bari, F Alongi, M Buglione, F Campostrini, A Briganti, G Berardi, ... Critical reviews in oncology/hematology 90 (1), 24-35, 2014 | 30 | 2014 |
| Choline-PET in prostate cancer management: the point of view of the radiation oncologist B De Bari, F Alongi, L Lestrade, F Giammarile Critical reviews in oncology/hematology 91 (3), 234-247, 2014 | 28 | 2014 |
| From radiobiology to technology: what is changing in radiotherapy for prostate cancer B De Bari, A Fiorentino, S Arcangeli, P Franco, RM D'Angelillo, F Alongi Expert review of anticancer therapy 14 (5), 553-564, 2014 | 28 | 2014 |
| Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature B De Bari, A Daidone, F Alongi Critical reviews in oncology/hematology 94 (3), 360-370, 2015 | 27 | 2015 |
| Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study M Balducci, S Chiesa, B Diletto, GR D'Agostino, A Mangiola, S Manfrida, ... Neuro-oncology 14 (1), 79-86, 2012 | 27 | 2012 |
| Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies B De Bari, AR Filippi, R Mazzola, P Bonomo, M Trovò, L Livi, F Alongi Cancer treatment reviews 41 (6), 511-518, 2015 | 26 | 2015 |
Filippo AlongiDirettore Radioterapia Oncologica, Ospedale Sacro Cuore, Negrar (Verona)Email verificata su sacrocuore.it
